Back to 
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCPRPRAX
Showing 0 of 2 quarters
Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in PRAXIS PRECISION MEDICINES I
No. UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS exited its PRAX (Praxis Precision Medicines) position in Q4 2022. Its Q3 2022 13F listed 26,204 shares worth $59,483. UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS first reported PRAX in Q3 2022 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.